Evidence map›Paper›PMID 32094154›Full record

Trial reportThorax2020

Prospective community programme versus parent-driven care to prevent respiratory morbidity in children following hospitalisation with severe bronchiolitis or pneumonia.

Catherine Ann Byrnes, Adrian Trenholme, Shirley Lawrence, Harley Aish, Julie Anne Higham, Karen Hoare, Aileen Elborough, Charissa McBride, Lyndsay Le Comte, Christine McIntosh and 9 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Thorax, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. 'You have to do what is best': The lived reality of having a child who is repeatedly hospitalized because of acute lower respiratory infection.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Catherine Ann ByrnesDepartment of Paediatrics, Child and Youth Health, The University of Auckland, Auckland, New Zealand c.byrnes@auckland.ac.nz.ORCID 0000-0002-3032-3172
Adrian TrenholmeDepartment of Paediatrics, Child and Youth Health, The University of Auckland, Auckland, New Zealand.
Shirley LawrenceDepartment of Paediatrics, KidzFirst Hospital Middlemore, Auckland, New Zealand.
Harley AishOtara Family and Christian Health Centre, Otara, Auckland, New Zealand.
Julie Anne HighamHunter Corner Medical Centre, Papatoetoe, Auckland, New Zealand.
Karen HoareGreenstone Family Clinic, Manurewa, Auckland, New Zealand.
Aileen ElboroughPukekohe Family Health Centre, Pukekohe, Auckland, New Zealand.
Charissa McBrideDepartment of Paediatrics, KidzFirst Hospital Middlemore, Auckland, New Zealand.
Lyndsay Le ComteCounties Manukau District Health Board, Middlemore Clinical Trials Unit, Auckland, New Zealand.
Christine McIntoshDepartment of Paediatrics, KidzFirst Hospital Middlemore, Auckland, New Zealand.
Florina Chan MowDepartment of Paediatrics, KidzFirst Hospital Middlemore, Auckland, New Zealand.
Mirjana JaksicDepartment of Paediatrics, Child and Youth Health, The University of Auckland, Auckland, New Zealand.
Russell MetcalfeDepartment of Radiology, Starship Children's Health, Auckland, New Zealand.
Christin CoomarasamyResearch and Evaluation Office, Koawatea, Auckland, New Zealand.
William LeungDepartment of Health Economy, Wellington School of Medicine, University of Otago, Wellington, New Zealand.
Alison VogelDepartment of Paediatrics, KidzFirst Hospital Middlemore, Auckland, New Zealand.
Teuila PercivalDepartment of Paediatrics, KidzFirst Hospital Middlemore, Auckland, New Zealand.
Henare MasonKoawatea, Middlemore Hospital, Auckland, New Zealand.
Joanna StewartDepartment of Population Health, The University of Auckland, Auckland, New Zealand.
Middlemore Hospital · NZUniversity of Auckland · NZMiddlemore Clinical Trials · NZStarship Children's Health · NZThe Family Centre · NZUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHospitalisation with severe lower respiratory tract infection (LRTI) in early childhood is associated with ongoing respiratory symptoms and possible later development of bronchiectasis. We aimed to reduce this intermediate respiratory morbidity with a community intervention programme at time of discharge.

methodsThis randomised, controlled, single-blind trial enrolled children aged <2 years hospitalised for severe LRTI to 'intervention' or 'control'. Intervention was three monthly community clinics treating wet cough with prolonged antibiotics referring non-responders. All other health issues were addressed, and health resilience behaviours were encouraged, with referrals for housing or smoking concerns. Controls followed the usual pathway of parent-initiated healthcare access. After 24 months, all children were assessed by a paediatrician blinded to randomisation for primary outcomes of wet cough, abnormal examination (crackles or clubbing) or chest X-ray Brasfield score ≤22.

findings400 children (203 intervention, 197 control) were enrolled in 2011-2012; mean age 6.9 months, 230 boys, 87% Maori/Pasifika ethnicity and 83% from the most deprived quintile. Final assessment of 321/400 (80.3%) showed no differences in presence of wet cough (33.9% intervention, 36.5% controls, relative risk (RR) 0.93, 95% CI 0.69 to 1.25), abnormal examination (21.7% intervention, 23.9% controls, RR 0.92, 95% CI 0.61 to 1.38) or Brasfield score ≤22 (32.4% intervention, 37.9% control, RR 0.85, 95% CI 0.63 to 1.17). Twelve (all intervention) were diagnosed with bronchiectasis within this timeframe.

interpretationWe have identified children at high risk of ongoing respiratory disease following hospital admission with severe LRTI in whom this intervention programme did not change outcomes over 2 years. TRIAL REGISTRATION NUMBER: ACTRN12610001095055.

Indexed as

Anti-Bacterial AgentsBronchiectasisBronchiolitisCaregiversCommunity Health ServicesFemaleFollow-Up StudiesHospitalizationHumansInfantMaleNew ZealandOutcome Assessment, Health CareParentsPneumonia, BacterialPrognosisAnti-Bacterial Agentsbronchiectasispaediatric lung disaesepneumoniarespiratory infection

Identifiers

PMID32094154
PMCPMC7231446
OpenAlexW3008113344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.